Obaob, Emelyn C.

HRN: 28-41-48  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/13/2026
CEFTRIAXONE 1G (VIAL)
01/13/2026
01/20/2026
IV
2gm
OD
Lacerated Wound
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: